Private company

Koronis Pharmaceuticals

Logo: Vaccinationist, Public domain, via Wikimedia Commons3

American biotechnology company

Koronis Pharmaceuticals is a Seattle area biotechnology company founded in 1998. Koronis is dedicated to the development of antiviral therapeutics based on a novel mechanism, Viral Decay Acceleration (VDA). The Company's lead product candidate is KP-1461 for the treatment of human immunodeficiency virus (HIV) infection.2 Wikipedia text CC BY-SA 4.0

Last updated Oct 21, 2026.

Overview

Koronis Pharmaceuticals is a Seattle area biotechnology company founded in 1998. Koronis is dedicated to the development of antiviral therapeutics based on a novel mechanism, Viral Decay Acceleration (VDA). The Company's lead product candidate is KP-1461 for the treatment of human immunodeficiency virus (HIV) infection. The company also has products in development for the treatment of hepatitis C and RSV infection.2

Sources

The numbers on this page point here. Each one links to the record it came from.

  1. 1
  2. 2
  3. 3